Strides Pharma Science's arm to exit investment in Arrow

30 Jan 2019 Evaluate

Strides Pharma Science’s step-down subsidiary -- Strides Pharma Global Pte has approved the sale of its entire Australian business (Including Arrow). The transaction will be subject to shareholder approval of Strides and completion of the merger of Arrow and Apotex Australia.

The initial net proceeds of AUD 300 million ($213 million) along with additional $42 million released from the general claims escrow account on Agila transaction. The company will sell its complete stake in Arrow to entities owned and operated by Dennis Bastas.

Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.

Strides Pharma Scien Share Price

878.65 -7.00 (-0.79%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×